For US Veterinary Professionals Only

HEAR THE DIFFERENCE BRAVECTO® IS MAKING

Across the country and around the world, veterinarians like yourself are discovering the difference 12-week* protection with Bravecto makes for dogs, cats and their clinic. Watch their stories to hear how.

Dr. John Issacs
North Carolina

"The benefits of Bravecto's proven safety and long-lasting efficacy against infestations for dogs and cats."

Dr. Michael Norris
New Hampshire

"The efficacious long-lasting protection of Bravecto helps make training and inventory easy."

Dr. Cathy Lund
Rhode Island

"The safety profile of Bravecto provides confidence, and the long-lasting efficacy addresses flea infestations in the cat's home."

Dr. Don Costlow
New York

"The 12-week* protection of Bravecto provides less stress and less complication for pet owners."

Dr. Sandy Merchant
Louisiana

"Bravecto is easy to offer to clients and administer, making pet owners happy."

Dr. Paul Ulrich
California

"The benefits of highly effective and easy-to apply 12-week* protection for cats."

Dr. Craig Prior
Tennessee

"Bravecto goes a long way in solving clients' flea and tick problems, so they'll keep coming back to the clinic."

Dr. Dan Markwalder
Illinois

"Bravecto is a popular choice among pet owners and the compliance numbers back it up."

Dr. Randal Bennett
Texas

"Bravecto gives pet owners the joy of a flea and tick-free household."

 
 
   
   

I irrevocably grant to Intervet Inc., a subsidiary of Merck & Co., Inc. and its affiliates and their respective officers, directors, employees, agents, successors, licensees and assigns (collectively, "MERCK ANIMAL HEALTH"), the right to take, record, publish or obtain testimonials or other statements from me (collectively, the "Statements") and use, copy, modify, adapt, distribute, publish, display, exhibit and otherwise publish or display in any media, by any means, methods and technologies now known or hereafter to become known, either in whole or in part, the Statements for commercial and business purposes, including, but not limited to, educational, advertising, marketing and promotional materials.

I agree that no advertisement or other material need be submitted to me for any approval. I further waive any and all rights that I may have over the use, distribution, transfer, display, exhibition or other publication of any Statements, including, without limitation, any right to inspect and/or approve such use, publication, distribution, transfer, display, exhibition or other exploitation so long as such Statements are not substantively altered.

I hereby release and discharge, and agree to release and discharge, MERCK ANIMAL HEALTH and its affiliates and their respective officers, directors, employees, agents, successors, licensees and assigns from, and shall neither sue nor bring any proceeding against any such parties for, any claim or cause of action, whether now known or unknown, for defamation, violation of any moral rights, invasion of right of privacy, publicity or personality or any similar matter, or based upon or relating to any use, copying, modification, adaptation, publication, distribution, transfer, display, exhibition or other exploitation of any or all of the Statements.

I further agree that MERCK ANIMAL HEALTH has the right to attribute the Statements (or statements in different words which have substantially the same meaning) to me, which is an expression of my personal experience and belief, including, without limitation, the use of my name and image in connection therewith. I further acknowledge that I am to receive no compensation from MERCK ANIMAL HEALTH relating to the use, copying, modification, adaptation, publication, distribution, transfer, display, exhibition or other exploitation of any or all of the Statements as set forth in this Release or the use of my name and/or image in connection therewith.

Nothing herein will constitute any obligation on MERCK ANIMAL HEALTH to make any use of the Statements or use of any of the rights set forth herein.

I represent and warrant that I am over the age of eighteen (18) years and have read and understand the contents of this Release.  

 

CONTACT US ABOUT THE 12-WEEK* DIFFERENCE

Have questions or comments about Bravecto? Contact us today so that we can help you start prescribing Bravecto for the dogs and cats at your clinic.

Contact Us

For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.

Bravecto kills fleas and prevents flea infestations. Bravecto Chew and Bravecto Topical Solution for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. Bravecto Topical for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.

IMPORTANT SAFETY INFORMATION:
Bravecto has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Bravecto Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. Bravecto Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Use caution in dogs with a history of seizures. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures. Bravecto Topical for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of Bravecto has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities.

Reference: 1. Data on file, Merck Animal Health, Madison, NJ. 2013.

Contact Us